I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Manglaviti, S.
13
results:
Search for persons
X
Format
Online (13)
Mediatypes
Articles (Online) (9)
OpenAccess-fulltext (4)
Sorted by: Relevance
Sorted by: Year
?
1
Efficacy and safety of ramucirumab plus carboplatin and pac..:
Proto, C.
;
Ganzinelli, M.
;
Manglaviti, S.
...
Annals of Oncology. , 2024
Link:
https://doi.org/10.1016/..
?
2
165P Tissue genomic profiling of pleural mesothelioma patie..:
Ambrosini, P.
;
Brambilla, M.
;
Marchesi, S.
...
ESMO Open. 9 (2024) - p. 102741 , 2024
Link:
https://doi.org/10.1016/..
?
3
68P OncoMutational ratio on ctDNA: A potential novel biomar..:
Ambrosini, P.
;
Provenzano, L.
;
Bottiglieri, A.
...
Journal of Thoracic Oncology. 18 (2023) 4 - p. S79-S80 , 2023
Link:
https://doi.org/10.1016/..
?
4
EP08.01-006 Using Real World data to build effective predic..:
prelaj, A.
;
Galli, E.G.
;
Pesenti, M.
...
Journal of Thoracic Oncology. 17 (2022) 9 - p. S337-S338 , 2022
Link:
https://doi.org/10.1016/..
?
5
MA10.07 Phase II Trial of Sunitinib in Patients with Type B..:
Proto, C.
;
Galli, G.
;
Manglaviti, S.
...
Journal of Thoracic Oncology. 17 (2022) 9 - p. S79-S80 , 2022
Link:
https://doi.org/10.1016/..
?
6
25P Platinum-based chemotherapy (PCT) addition to first-lin..:
Ferrara, R.
;
Lo Russo, G.
;
Ciniselli, C.M.
...
Immuno-Oncology and Technology. 16 (2022) - p. 100130 , 2022
Link:
https://doi.org/10.1016/..
?
7
P1.15-02 Plasma microRNAs Modulation in Advanced NSCLC Pati..:
Proto, C.
;
Chiaruttini, M.V.
;
Prelaj, A.
...
Journal of Thoracic Oncology. 17 (2022) 9 - p. S119-S120 , 2022
Link:
https://doi.org/10.1016/..
?
8
PEOPLE (NCT03447678), a first-line phase II pembrolizumab t..:
Lo Russo, G.
;
Sgambelluri, F.
;
Prelaj, A.
...
ESMO Open. 7 (2022) 6 - p. 100645 , 2022
Link:
https://doi.org/10.1016/..
?
9
EP07.01-021 Clinical and Biochemical Profiling of Pleural M..:
Occhipinti, M.
;
Tacchetto, A.
;
Beninato, T.
...
Journal of Thoracic Oncology. 17 (2022) 9 - p. S322-S323 , 2022
Link:
https://doi.org/10.1016/..
?
10
PEOPLE (NCT03447678), a first-line phase II pembrolizumab t..:
Lo Russo, G
;
Sgambelluri, F
;
Prelaj, A
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808469/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
11
Machine Learning Using Real-World and Translational Data to..:
Prelaj A
;
Boeri M
;
Robuschi A
...
info:eu-repo/semantics/altIdentifier/pmid/35053597. , 2022
Link:
http://hdl.handle.net/24..
?
12
Evaluation of drug-drug interactions in EGFR-mutated non-sm..:
Occhipinti, M
;
Brambilla, M
;
Galli, G
...
info:eu-repo/semantics/altIdentifier/pmid/34069851. , 2021
Link:
http://hdl.handle.net/11..
?
13
Evaluation of drug-drug interactions in EGFR-mutated non-sm..:
Occhipinti M
;
Brambilla M
;
Galli G
...
info:eu-repo/semantics/altIdentifier/pmid/34069851. , 2021
Link:
http://hdl.handle.net/24..
1-13
